Among active 13F managers last quarter, 2 opened and none reduced or exited; the largest holder to move was Act Capital Management, LLC (new position). Over the last 180 days, 2 insiders bought and none sold, a net $0 in open-market trades.
Funds lean in and no leg opposes.
3 tracked 13F filers disclose a position in CGEH as of the latest SEC 13F filings, a combined $264K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Act Capital Management, LLC | 28K | $253K | ▲New +28K sh | Q2 2026 | |
| 2 | Accent Capital Management, LLC | 925 | $9K | ▲New +925 sh | Q2 2026 | |
| 3 | Arlington Trust Co LLC | 300 | $3K | ▲New +300 sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 2 funds opened a new position in CGEH, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Krystal Biotech IncKRYS | 2 funds | $16.7M |
| Amazon.com IncAMZN | 2 funds | $13.9M |
| TG Therapeutics IncTGTX | 2 funds | $13.8M |
| Chevron CorpCVX | 2 funds | $12.5M |
| Tesla IncTSLA | 2 funds | $9.0M |
| Arrowhead Pharmaceuticals InARWR | 2 funds | $9.0M |
| Ast Spacemobile IncASTS | 2 funds | $3.9M |
| Freeport-McMoran IncFCX | 2 funds | $2.7M |
| Bloom Energy Corp- ABE | 2 funds | $2.3M |
| Nokia Corp-Spon ADRNOK | 2 funds | $1.1M |
| Praxis Precision Medicines IPRAX | 2 funds | $921K |
| Axt IncAXTI | 2 funds | $361K |
Ranked by how many of CGEH's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in CGEH.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Fu Ping | Director | Buy (P) | 0 | $0 |
| Sep 1, 2026 | Wilson Denise | Director | Buy (P) | 0 | $0 |
| Nov 25, 2025 | Graves Candice | Chief Accounting Officer | Buy (P) | 10K | $20K |
| Nov 25, 2025 | Miller John P. | Interim CFO, Director | Buy (P) | 25K | $50K |
| Nov 25, 2025 | Powelson Robert F | Director | Buy (P) | 13K | $25K |
| Nov 25, 2025 | Beard Robert F. | Director | Buy (P) | 13K | $25K |
| Nov 25, 2025 | Canino Vincent J. | President & CEO, Director | Buy (P) | 75K | $150K |
| Nov 25, 2025 | Close Christopher J. | Director | Buy (P) | 13K | $25K |
| Nov 21, 2022 | Jamison Darren | President & CEO, Director | Buy (P) | 32K | $57K |
| Nov 21, 2022 | Robinson Scott W. | InterimChief Financial Officer | Buy (P) | 4K | $7K |
| Nov 19, 2021 | Jamison Darren | President & CEO, Director | Buy (P) | 5K | $26K |
| Sep 8, 2021 | Jamison Darren | President & CEO, Director | Buy (P) | 8K | $31K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 0 | 0 | – |
Insiders Form 4 open-market | 2 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for CGEH
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CGEH/capital-change-brief"
Use Arkolith's capital_change_brief for CGEH. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + the live filing stream, joined for CGEH. Filings are public domain, sourced to SEC EDGAR.